Trial intelligence / Profile preview

Levetiracetam 1 week versus 4 weeks after glioma surgery in patients without preoperative seizures

ChiCTR2000030052Phase 4Not yet recruiting

Sponsor
Beijing Tiantan Hospital
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of levetiracetam in epilepsy (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Engel outcome classification. Planned start May 2020; status: not yet recruiting.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on ChiCTR2000030052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000030052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call